Senior insider sale
See Remarks at TARSUS PHARMACEUTICALS, INC. — senior position signals high conviction
$1.32M
20.83K shares
What this filing means
FARROW JEFFREY S plans to sell 20.83K shares of TARSUS PHARMACEUTICALS, INC. valued at approximately $1.32M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/16/2026ACC: 0001959173-26-004721
Officer· See Remarks
Since Mar 2026
20.83K
Shares to sell
$1.32M
Approx. market value
14.40K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
6/15/2026
14.40KTotal acquired14.40K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/15/2026 | Restricted Stock Vesting Compensation | 14.40K | — |
| Total | 14.40K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
2.19K
Market value
$146.5K
3/19/2026
—Completed
Units to sell
2.13K
Market value
$146.6K
3/18/2026
—Completed
Units to sell
2.11K
Market value
$146.5K
3/17/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
14.40K
Market value
$877.5K
6/16/2026
Total
Units
20.83K
Value
$1.32M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/19/2026 | 2.19K | $146.5K | — | Completed |
3/18/2026 | 2.13K | $146.6K | — | Completed |
3/17/2026 | 2.11K | $146.5K | — | Completed |
| Planned — Approximate Date | ||||
6/16/2026 | 14.40K | $877.5K | NASDAQ | Planned |
| Total | 20.83K | $1.32M | ||